NURIX THERAPEUTICS INC's ticker is NRIX and the CUSIP is 67080M103. A total of 119 filers reported holding NURIX THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $7,530,998 | -3.0% | 958,043 | +23.2% | 0.00% | 0.0% |
Q2 2023 | $7,767,374 | +38.1% | 777,512 | +22.7% | 0.00% | 0.0% |
Q1 2023 | $5,625,322 | +87672.2% | 633,517 | +8.5% | 0.00% | 0.0% |
Q4 2022 | $6,409 | -99.9% | 583,742 | +74.4% | 0.00% | 0.0% |
Q3 2022 | $4,362,000 | +68.5% | 334,725 | +63.8% | 0.00% | +100.0% |
Q2 2022 | $2,588,000 | -22.2% | 204,302 | -14.0% | 0.00% | 0.0% |
Q1 2022 | $3,328,000 | -1.2% | 237,525 | +104.1% | 0.00% | 0.0% |
Q4 2021 | $3,369,000 | – | 116,358 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 1,822,883 | $14,327,860 | 1.60% |
DAFNA Capital Management LLC | 556,695 | $4,375,623 | 1.36% |
Redmile Group, LLC | 2,848,827 | $22,391,780 | 1.06% |
Deep Track Capital, LP | 2,997,830 | $23,562,944 | 0.91% |
WestHill Financial Advisors, Inc. | 283,333 | $2,226,997 | 0.65% |
Soleus Capital Management, L.P. | 814,000 | $6,398,040 | 0.59% |
Affinity Asset Advisors, LLC | 250,000 | $1,965,000 | 0.55% |
Boxer Capital, LLC | 1,224,892 | $9,627,651 | 0.51% |
AtonRa Partners | 24,227 | $190,424 | 0.40% |
WASATCH ADVISORS LP | 3,564,616 | $28,017,882 | 0.18% |